Outsourcing

Articles

Emergent BioSolutions will help develop and manufacture an oral vaccine candidate and will develop plasma-based antibody therapeutics.

Emergent BioSolutions to Manufacture Oral Vaccine and Develop Antibody Therapeutics for COVID-19

Belgian-based bioprocessing provider, Univercells, has launched a CDMO, Exothera, that will support developers of cell and gene therapies through process development and production of viral vectors.


Univercells Launches CDMO to Support Cell and Gene Therapy Developers

FDA issued a notice to drug compounders regarding the transition of licensure of biologics to the Public Health Service Act. 

Biologics and Compounding Rules Change

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Understanding of scale-up parameters and use of process analytical technology are important to meet demand for larger batch sizes.

Challenges in Clinical Manufacturing for Topical Drugs

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

The huge potential of biopharma is presenting an important epoch for outsourcing partners that can support the development and manufacture of biologics in an efficient way.


By Popular Demand: The Growth of Biopharma Outsourcing

Alberto Santagostino is senior vice-president and head of cell and gene technologies at Lonza Pharma and Biotech. 

Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost. 

Using the ‘Cubic Effect’ to Drive Cell and Gene Therapy Commercialization

Catalent builds on its investment in cell and gene therapy development and manufacturing with the acquisition of MaSTherCell Global.

Catalent to Acquire MaSTherCell Global for $315 Million

Tim Roach is senior director of plant engineering at Recro Gainesville.

Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.

Best Practices for Design and Operation of Multiproduct Manufacturing Facilities

Kai Vogt is senior vice-president Corporate Development, Legal and Compliance, Information Technology at Vetter Pharma. 

CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects. 

Digitalization: A CDMO’s Perspective

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

The need for manufacturing speed inspires contract manufacturers to explore advanced processing technologies.

Contract Manufacturing Services